APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,567,700 | +28.3% | 67,500 | +207.2% | 0.09% | +23.3% |
| Q2 2023 | $2,002,014 | -66.7% | 21,976 | -75.9% | 0.07% | -70.0% |
| Q1 2023 | $6,004,009 | +62.8% | 91,025 | +68.6% | 0.24% | +38.1% |
| Q3 2022 | $3,688,000 | +79.7% | 54,000 | +33.7% | 0.18% | +87.2% |
| Q1 2022 | $2,052,000 | -9.6% | 40,377 | -15.9% | 0.09% | -24.8% |
| Q4 2021 | $2,270,000 | +292.1% | 48,013 | +255.7% | 0.12% | +557.9% |
| Q1 2021 | $579,000 | – | 13,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |